Myriad Genetics MYGN Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's other income (expense)?
- Myriad Genetics (MYGN) reported other income (expense) of -$3.4M in Q1 2026.
- How has Myriad Genetics's other income (expense) changed year-over-year?
- Myriad Genetics's other income (expense) decreased by 750.0% year-over-year, from -$400K to -$3.4M.
- What is the long-term trend for Myriad Genetics's other income (expense)?
- Over 4 years (2021 to 2025), Myriad Genetics's other income (expense) has grown at a -50.7% compound annual growth rate (CAGR), from $133.8M to -$7.9M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.